A lazaroid mitigates postresuscitation myocardial dysfunction

Critical Care Medicine

Volumn 32, Issue 2, 2004, Pages 553-558

  Wang, Jinglan ^a   Weil, Max Harry ^a,b   Kamohara, Takashi ^a   Tang, Wanchun ^a,b   Sun, Shijie ^a,b   Klouche, Kada ^a   Bisera, Joe ^a  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antioxidants; Cardiopulmonary resuscitation; Hemodynamics; Reperfusion; Survival

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; LAZAROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DEFIBRILLATION; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RIGHT ATRIUM; HEART VENTRICLE FIBRILLATION; MALE; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SURVIVAL;

ANIMALS; ANTIOXIDANTS; CARDIOMYOPATHIES; MALE; PREGNATRIENES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION;

EID: 1242342705     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000109776.56410.F1     Document Type: Article

References (49)

1. Liberthson RR, Nagel EL, Hirschman JC, et al: Prehospital ventricular defibrillation. Prognosis and follow-up course. N Engl J Med 1974; 291:317-321
2. Brown CG, Martin DR, Pepe P, et al: A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 1992; 327:1051-1055
3. Brain Resuscitation Clinical Trial I Study Group: Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986; 314:397-403
4. Stiell IG, Hebert PC, Weitzman BN, et al: High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992; 327:1045-1050
5. Tang W, Weil MH, Sun SJ, et al: Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med 1993; 21:1046-1050
6. Tang W, Weil MH, Sun SJ, et al: Epinephrine increases the severity of post-resuscitation myocardial dysfunction. Circulation 1995; 92:3089-3093
7. Gazmuri RJ, Weil MH, Bisera J, et al: Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 1996; 24:992-1000
8. Xie J, Weil MH, Sun S, et al: High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 1997; 96:683-688
9. Bolli R: Why myocardial stunning is clinically important. Basic Res Cardiol 1998; 93:169-172
10. Kloner RA, Przyklenk K, Whittaker P: Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989; 80:1115-1127
11. Ferrari R, Ceconi C, Curello S, et al: Occurrence of oxidative stress during myocardial reperfusion. Mol Cell Biochem 1992; 111:61-69
12. Nohl H, Stolze K, Napetschnig S, et al: Is oxidative stress primarily involved in reperfusion injury of the ischemic heart? Free Radic Biol Med 1991; 11:581-588
13. Monyer H, Hartley DM, Choi DW: 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 1990; 5:121-126
14. Krantis A, Harding RK, McKay AE, et al: Effects of compound U74500A in animal models of gastric and duodenal ulceration. Dig Dis Sci 1993; 38:722-729
15. Perna AM, Liguori P, Bonacchi M, et al: Protection of rat heart from ischaemia-reperfusion injury by the 21-aminosteroid U-74389G. Pharmacol Res 1996; 34:25-31
16. Nishida T, Morita S, Masuda M, et al: Lazaroid U74500A is superior to U74006F in preserving rabbit heart for 24 hours. Ann Thorac Surg 1998; 66:1647-1652
17. Campo GM, Squadrito F, Campo S, et al: Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury. Free Radic Res 1997; 27:577-590
18. Zhao W, Richardson JS, Mombourquette MJ, et al: An in vitro EPR study of the free-radical scavenging actions of the lazaroid antioxidants U-74500A and U-78517F. Free Radic Biol Med 1995; 19:21-30
19. Tseng MT, Chan SA, Reid K, et al: Post-ischemic treatment with a lazaroid (U74389G) prevents transient global ischemic damage in rat hippocampus. Neurol Res 1997; 19:431-434
20. Takahashi T, Takeyoshi I, Hasegawa Y, et al: Cardioprotective effects of lazaroid U-74389G on ischemia-reperfusion injury in canine hearts. J Heart Lung Transplant 1999; 18:285-291
21. Zhang H, Spapen H, Manikis P, et al: Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs. Am J Physiol 1995; 268:H1847-H1855
22. Spapen H, Zhang H, Vincent J: Potential therapeutic value of lazaroids in endotoxemia and other forms of sepsis. Shock 1997; 8:321-327
23. von Planta I, Weil MH, von Planta M, et al: Cardiopulmonary resuscitation in the rat. J Appl Physiol 1988; 65:2641-2647
24. Hendrickx HH, Rao GR, Safar P, et al: Asphyxia, cardiac arrest and resuscitation in rats. I. Short term recovery. Resuscitation 1984; 12:97-116
25. Tang W, Weil MH: Prevention and therapy of postresuscitation myocardial dysfunction. In: Cardiac Arrest. Paradis NA, Halperin HR, Nowak RM (Eds). Baltimore, Williams & Wilkins, 1996, pp 850-858
26. Idris AH, Gabrielli A, Caruso L, et al: Oxidant injury occurs rapidly after cardiac arrest, cardiopulmonary resuscitation (CPR), and reperfusion. Abstr. Circulation 2000; 102:II-571
27. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312:159-163
28. Thompson JA, Hess ML: The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 1986; 28:449-462
29. Nishida T, Morita S, Miyamoto K, et al: Lazaroid (U74500A) prevents vascular and myocardial dysfunction after 24-hour heart preservation. A study based on cross-circulated blood-perfused rabbit hearts. Circulation 1996; 94:II-326-II-331
30. Braughler JM, Pregenzer JF, Chase RL, et al: Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987; 262:10438-10440
31. Ryan TP, Steenwyk RC, Pearson PG, et al: Inhibition of in vitro lipid peroxidation by 21-aminosteroids. Evidence for differential mechanisms. Biochem Pharmacol 1993; 46:877-884
32. Campo GM, Squadrito F, Altavilla D, et al: Protection of ischemic and reperfused rat myocardium by the non-glucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidation. J Pharmacol Exp Ther 1996; 277:333-340
33. Holzgrefe HH, Buchanan LV, Gibson JK: Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium. J Cardiovasc Pharmacol 1990; 15:239-248
34. Levitt MA, Sievers RE, Wolfe CL: Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a non-glucocorticoid 21-aminosteroid. J Cardiovasc Pharmacol 1994; 23:136-140
35. Carrea FP, Lesnefsky EJ, Kaiser DG, et al: The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion. J Cardiovasc Pharmacol 1992; 20:230-235
36. Du ZY, Hicks M, Spratt P, et al: Cardioprotective effects of pinacidil pretreatment and lazaroid (U74500A) preservation in isolated rat hearts after 12-hour hypothermic storage. Transplantation 1998; 66:158-163
37. Hendry PJ, Anstadt MP, Plunkett MD, et al: Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J Heart Lung Transplant 1992; 11:636-645
38. Moreyra AE, Conway RS, Wilson AC, et al: Attenuation of myocardial stunning in isolated rat hearts by a 21-aminosteroid lazaroid (U74389G). J Cardiovasc Pharmacol 1996; 28:659-664
39. Duguay P, Chen H, Daloze P, et al: Cardio-protective effects of the lazaroid U74389G following cold preservation and transplantation of rat hearts. Transplantation 1996; 61:1023-1028
40. Hearse DJ, Kusama Y, Bernier M: Rapid electrophysiological changes leading to arrhythmias in the aerobic rat heart. Photosensitization studies with rose bengal-derived reactive oxygen intermediates. Circ Res 1989; 65:146-153
41. Wilson JT, Gross CE, Bednar MM, et al: U83836E reduces secondary brain injury in a rabbit model of cryogenic trauma. J Trauma 1995; 39:473-477
42. Clark WM, Hazel JS, Coull BM: Lazaroids. CNS pharmacology and current research. Drugs 1995; 50:971-983
43. Natale JE, Schott RJ, Hall ED, et al: Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 1988; 19:1371-1378
44. Vaziri ND, Din Y: Effect of lead on nitric oxide synthase expression in coronary endothelial cells. Hypertension 2001; 37:223
45. Sasaki S, Alessandrini F, Lodi R, et al: Improvement of pulmonary graft after storage for twenty-four hours by in vivo administration of lazaroid U74389G: Functional and morphologic analysis. J Heart Lung Transplant 15:35-42, 1996
46. Tanoue Y, Morita S, Ochiai Y, et al Successful twenty-four-hour canine lung preservation with lazaroid U74500A. J Heart Lung Transplant 1996; 15:43-50
47. Takeyoshi I, Iwanami K, Kamoshita N, et al: Effect of lazaroid U74389G on pulmonary ischemia-reperfusion injury dogs. J Invest Surg 2001; 14:83-92
48. van Klaveren RJ, Roelant C, Boogaerts M, et al: Protective effects of the lazaroid U74389G against hyperoxia in rat type II pneumocytes. Pulm Pharmacol Ther 1998; 11:23-30
49. Miniati M, Cocci F, Monti S, et al: Lazaroid U74389F attenuates phorbol ester-induced lung injury in rabbits. Eur Respir J 1996; 9:758-764